01
Neuroscience & Neurotechnology
Next-generation technologies across neurodegeneration, neuromodulation, neurodiagnostics and neurological care pathways.
Technology Areas
Not what is fashionable — what has mechanism, evidence and credible use.
This is not a product catalogue. It brings together the fields I follow — from neuroscience and extracellular vesicles to peptides and cellular metabolism — through evidence quality and translational reality.
01 · Exosomes02 · Peptides03 · NAD⁺04 · Mitochondria05 · Neuroscience06 · Advanced Medical
02
Exosomes & Extracellular Vesicles
Biomarker, cell-communication and therapeutic-platform potential assessed together with manufacturing, characterisation and translational limitations.
03
Peptides & Molecular Platforms
Peptide biology, targeted signalling mechanisms and the distinction between research-stage approaches and clinical evidence.
04
NAD⁺, Mitochondria & Metabolism
Cellular energy, redox balance, mitochondrial biology and developing platforms in ageing and neurodegeneration.
05
Digital Health & AI
Clinical decision support, remote monitoring, health-data analytics and AI-enabled healthcare solutions.
06
Advanced Medical & Laboratory Technologies
Selected systems that can create measurable value in diagnosis, monitoring, analytical laboratories and clinical workflows.
Evidence Boundary
An interesting mechanism is not the same as clinical evidence.
For exosomes, peptides and metabolic platforms in particular, preclinical findings, human evidence, standardisation challenges and regulatory reality need to be read separately. The writing and consulting approach preserves that distinction.
Assessment Criteria
Why does a technology enter my focus?
Being new or popular is not enough. Science, need, safety, applicability and real-world value need to work together.
01
Addresses a real biological, clinical or technical need
02
Provides a reviewable scientific basis and credible evidence
03
Allows preclinical findings to be clearly separated from human evidence
04
Can be assessed for safety, manufacturability and standardisation
05
Has a realistic use case or market route in Türkiye